Gandhar Oil Reports Q1 Consolidated Net Profit of ₹205.89 Crore

Market snapshot: Gandhar Oil Refinery (India) Limited declared its consolidated financial results for the first quarter ended June 30, 2026, delivering an exceptional surge in performance. While the original news alert claimed a Q1 consolidated net profit of 1.92B Rupees (₹192 crore) (as stated in the source alert; not independently verified), official regulatory filings submitted to BSE and NSE confirm that the consolidated Net Profit actually stood at ₹205.89 crore.

Data Snapshot

• Consolidated Net Profit (PAT) for the quarter ended June 30, 2026, reached ₹205.89 crore, reflecting a massive YoY expansion.
• Consolidated Revenue from Operations stood at ₹1,731.93 crore, up significantly on both YoY and QoQ bases.
• Texol Lubritech FZC, a key subsidiary, reported total revenue of ₹144.54 crore and a net profit after tax of ₹27.30 crore for the quarter.

What's Changed

• Consolidated Net Profit increased to ₹205.89 crore in Q1 FY27, up from ₹26.23 crore in Q1 FY26 and ₹40.68 crore in Q4 FY26.
• Consolidated Revenue from Operations rose to ₹1,731.93 crore, compared to ₹902.96 crore in Q1 FY26 and ₹1,093.37 crore in Q4 FY26.

Key Takeaways

• Extraordinary volume expansions and robust operations across both domestic and international markets drove Q1 FY27 growth.
• The performance shows strong operating leverage, with PAT growing far quicker than top-line revenue.
• The company's subsidiary, Texol Lubritech FZC, remains a core driver of profitable international expansion, generating a net profit of ₹27.30 crore.
• The results set a highly positive tone for the 2026-27 financial year, showing resilience against raw material and logistics headwinds.

SAHI Perspective

Gandhar Oil Refinery has demonstrated superb operational resilience. By delivering a significant jump in margins alongside substantial revenue growth, the company highlights its pricing power and capacity to pass on base oil cost fluctuations to consumers. The strong performance of its foreign subsidiary further solidifies its positioning as a global specialty oils major.

Market Implications

The exceptional earnings performance is likely to generate extremely positive momentum for the stock in the near term. Analysts will closely monitor the scheduled earnings call on July 23, 2026, for management updates on volume guidance, international expansion, and margin sustainability.

Trading Signals

Market Bias: Bullish

The highly positive directional bias is backed by a massive ≈684.94% YoY surge in consolidated net profit to ₹205.89 crore and a 91.81% YoY increase in revenue to ₹1,731.93 crore, driven by robust domestic and subsidiary performances.

Overweight: Specialty Chemicals, Petrochemicals

Trigger Factors:

• Sustainability of the PHPO segment margins
• Stable base oil raw material costs
• Post-earnings call commentary scheduled for July 23, 2026

Time Horizon: Near-term (0-3 months)

Industry Context

Gandhar Oil Refinery is one of India's largest manufacturers of white oils and ranks among the top five players globally, commanding a 26.5% market share in India and a 9.6% market share globally. It operates in the highly specialized petrochemicals sub-sector, serving pharmaceutical, personal care, and industrial segments.

Key Risks to Watch

• Raw material volatility: Variations in base oil prices directly impact manufacturing margins.
• Geopolitical constraints: Disruption in shipping lanes or supply chains could impact export logistics.
• Foreign exchange risks: Fluctuations in major currencies may affect realization of overseas revenues.

Recent Developments

On July 21, 2026, Neomile Growth Fund - Series I acquired 8.64 lakh shares (representing a 0.88% stake) in Gandhar Oil Refinery India at ₹224.80 per share, through a transaction valued at ₹19.4 crore. Additionally, the company has scheduled its Q1 FY27 earnings call with analysts and investors on Thursday, July 23, 2026, at 11:00 AM IST.

Closing Insight

Gandhar Oil Refinery's Q1 FY27 performance marks a robust start to the fiscal year, proving that its strategic shift toward higher-value pharmaceutical and healthcare specialty oils is paying off handsomely.

High Performance Trading with SAHI.